Patents by Inventor Michael Katze

Michael Katze has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biomarkers For Early Determination Of Severity Of Influenza Related Disease
    Publication number: 20190076484
    Abstract: The present invention relates to the use of at least one biomarker for predicting the severity of a disease caused by the infection of an individual with an influenza virus, wherein said biomarker is selected in a group comprising (i) the alpha diversity value of the microbiome present in a respiratory sample of said individual and (ii) the microbiome profile of the said respiratory sample.
    Type: Application
    Filed: September 23, 2016
    Publication date: March 14, 2019
    Applicants: Universite Claude Bernard Lyon 1, Hospices Civils de Lyon, University of Washington
    Inventors: Laurence Josset, Maxime Pichon, Bruno Lina, Michael Katze, Stanley Langevin
  • METHODS AND COMPOSITIONS FOR DIAGNOSING HEPATOCELLULAR CARCINOMA
    Publication number: 20100172833
    Abstract: Methods for the diagnosis of hepatocellular carcinoma (HCC) are set forth. Improved assay methods and scanning methods are included that employ non-cell-associated and cell-associated HCC related proteins. Such methods are based upon the discovery of genes that were up-regulated in diseased versus normal tissue as well as in HCC tissue when compared to the tissue of patients with other ailments.
    Type: Application
    Filed: August 7, 2009
    Publication date: July 8, 2010
    Applicants: ILLUMIGEN BIOSCIENCES, INC., UNIVERSITY OF WASHINGTON
    Inventors: Michael Katze, Roger Bumgarner, Mariya Smit, Gary Rosenberg
  • Methods and compositions for diagnosing hepatocellular carcinoma
    Patent number: 7588902
    Abstract: Methods for the diagnosis of hepatocellular carcinoma (HCC) are set forth. Improved assay methods and scanning methods are included that employ non-cell-associated and cell-associated HCC related proteins. Such methods are based upon the discovery of genes that were up-regulated in diseased versus normal tissue as well as in HCC tissue when compared to the tissue of patients with other ailments.
    Type: Grant
    Filed: July 3, 2003
    Date of Patent: September 15, 2009
    Assignee: Illumigen Biosciences, Inc.
    Inventors: Michael Katze, Roger Bumgarner, Mariya Smit, Gary Rosenberg
  • Method for selective inactivation of viral replication
    Publication number: 20070218470
    Abstract: Method for screening for an antiviral agent, by determining whether a potential agent interacts with a virus or cellular component which allows or prevents preferential translation of a virus RNA compared to a host RNA under virus infection conditions; and determining whether any interaction of the agent with the component reduces the level of translation of an RNA of the virus.
    Type: Application
    Filed: October 4, 2006
    Publication date: September 20, 2007
    Inventors: Vincent Miles, Michael Mathews, Michael Katze, Julia Watson, Gary Witherell
  • Methods and compositions for diagnosing hepatocellular carcinoma
    Publication number: 20070161058
    Abstract: Methods for the diagnosis of hepatocellular carcinoma (HCC) are set forth. Improved assay methods and scanning methods are included that employ non-cell-associated and cell-associated HCC related proteins. Such methods are based upon the discovery of genes that were up-regulated in diseased versus normal tissue as well as in HCC tissue when compared to the tissue of patients with other ailments.
    Type: Application
    Filed: July 3, 2003
    Publication date: July 12, 2007
    Applicants: Illumigen Biosciences, University of Washington
    Inventors: Michael Katze, Roger Bumgarner, Mariva Smit, Gary Rosenburg
  • Method for selective inactivation of viral replication
    Publication number: 20050265975
    Abstract: Method for screening for an antiviral agent, by determining whether a potential agent interacts with a virus or cellular component which allows or prevents preferential translation of a virus RNA compared to a host RNA under virus infection conditions; and determining whether any interaction of the agent with the component reduces the level of translation of an RNA of the virus.
    Type: Application
    Filed: August 1, 2005
    Publication date: December 1, 2005
    Inventors: Vincent Miles, Michael Mathews, Michael Katze, Julia Watson, Gary Witherell